Skip to main content
main-content

Latest news

Free registration

Medicine Matters was developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by


Editors' pick

23-04-2018 | Gout | News

Verinurad–febuxostat combination shows promise for the treatment of gout

Results of a phase IIa trial support further investigation of the selective URAT1 inhibitor verinurad in combination with febuxostat for the treatment of gout.

Source:

RMD Open 2018; 4: e000647

Latest headlines

26-04-2018 | Systemic lupus erythematosus | News

Promising results for subcutaneous belimumab in subset of SLE patients

Treatment with subcutaneous belimumab may be beneficial for patients with SLE who are hypocomplementemic and positive for antibodies against double-stranded DNA, subgroup analyses of a phase III trial suggest.

Source:

Arthritis Rheumatol 2018; Advance online publication

25-04-2018 | Gout | News

Ethnicity may be a risk factor for allopurinol hypersensitivity

People of Black, Asian, or Native Hawaiian/Pacific Islander ethnicity have a substantially higher risk for allopurinol-associated severe cutaneous adverse reactions than White and Hispanic individuals, US researchers report.

Source:

Ann Rheum Dis 2018; Advance online publication

24-04-2018 | Spondyloarthropathy | News

Pain, comorbidity burden high in patients with spondyloarthritis

Results of two studies emphasize the important of taking pain and comorbidities into account when treating patients with spondyloarthritis.

Source:

BMC Rheumatology 2018; 2: 11
Clin Rheumatol 2018; Advance online publication

23-04-2018 | Gout | News

Verinurad–febuxostat combination shows promise for the treatment of gout

Results of a phase IIa trial support further investigation of the selective URAT1 inhibitor verinurad in combination with febuxostat for the treatment of gout.

Source:

RMD Open 2018; 4: e000647

20-04-2018 | Juvenile idiopathic arthritis | News

JIA recommendations define treat-to-target strategy

An international taskforce has developed consensus recommendations for treating juvenile idiopathic arthritis to target.

Source:

Ann Rheum Dis 2018; Advance online publication

19-04-2018 | Certolizumab pegol | News

‘Reassuring’ data on certolizumab pegol use during pregnancy

Treatment with the tumor necrosis factor inhibitor certolizumab pegol during pregnancy is not likely to be associated with teratogenic effects, researchers report.

Source:

Arthritis Rheumatol 2018; Advance online publication

In depth

06-04-2018 | Spondyloarthropathy | Feature | Article

At a glance: Trials of tofacitinib in spondyloarthritis

A quick-reference guide to the published and ongoing clinical trials of tofacitinib for the treatment of spondyloarthritis.

09-02-2018 | Rheumatoid arthritis | Feature | News

Should treatment be tapered in patients with RA?

medwireNews speaks to Vivian Bykerk about whether treatment should be tapered in patients with rheumatoid arthritis.

Talking to patients about biosimilar drugs

In this medwireNews podcast, Editorial Board member Victoria Ruffing discusses how to talk to patients about biosimilar drugs, and outlines questions and concerns they may have.

image credits